Categories
Anticancer Drugs Oncology Palonosetron Pharmacology Physiotherapy

Palonosetron and Renal Impairment

In this article we will discuss Palonosetron and Renal Impairment

In this article, we will discuss Palonosetron and Renal Impairment. So, let’s get started.

Palonosetron and Renal Impairment

Mild to moderate renal impairment does not significantly affect palonosetron
pharmacokinetic parameters. Total systemic exposure increased by approximately 28% in severe renal impairment relative to healthy subjects. This increase is not considered clinically meaningful.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.